NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Clinical trial NCT01688037 · COMPLETED
Trial details
- NCT number
- NCT01688037
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2013-09-01
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.